It is also intriguing that, like Podocalyxin, podoplanin has been proposed to play a functional role in metastatic carcinoma progression by altering polarization rather than by initiating a classical epithelial to mesenchymal transformation [8], [39]. The gene discussed is PDPN; the disease is metastatic carcinoma.